IXICO PLC  

(Public, LON:IXI)   Watch this stock  
Find more results for Charles Lowther�
47.00
-2.00 (-4.08%)
Oct 24 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 47.00 - 48.00
52 week 37.00 - 145.00
Open 49.00
Vol / Avg. 4,282.00/3,039.00
Mkt cap 7.23M*
P/E     -
Div/yield     -
EPS -0.69*
Shares 15.06M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q3 (Sep '13) 2013
Net profit margin -21131.60% -47670.00%
Operating margin -21259.60% -51800.00%
EBITD margin - -51540.00%
Return on average assets -69.04% -60.56%
Return on average equity -90.08% -79.68%
Employees 9 -
CDP Score - -

Address

4th Floor/ Griffin Court/ 15 Long Lane
LONDON, ENG NW1 0NH
United Kingdom - Map
+44-20-37637499 (Phone)
+44-20-72092473 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

IXICO plc, formerly Phytopharm plc, is engaged in researching, diagnosing and treating serious diseases. While the clinical focus is dementia, the Company also supports clinical studies for other disease areas in the field of neuro-degeneration. The Company�s medical image management and analysis products are used by the global pharmaceutical industry to select patients for clinical trials and to assess the safety and efficacy of drugs in development. The Company�s technologies include TrialWire and TrialTracker. This technology has been used in the collection of patient data from more than 400 hospital sites worldwide in several of the clinical trials of Alzheimer�s disease treatments. The Company is also translating its technology into decision-support tools for the diagnosis of dementia. These products, including the new medical device, Assessa, will assist healthcare professionals to provide diagnosis.

Officers and directors

Andy Richards Chairman of the Board
Derek Hill Ph.D. Chief Executive Officer, Director
Susan Day Lowther Chief Financial Officer
Age: 54
Roger Humm Vice President - Finance
Jane Whitrow Vice President - Business Operations, Company Secretary, Director
Michelle Lax Vice President - Clinical Operations
Charles Spicer Vice President - Corporate Development, Director
Age: 48
Kate McLeish PhD. Vice President - Technology
John Hall Vice President - Business Development
Maina Bhaman Non-Executive Director